COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,796 Articles (22,527 medRxiv, 8,269 bioRxiv)

Most recent first Previous |  Page 402: Articles 4011-4020  | Next

Knowledge of COVID-19 Symptoms, Transmission, and Prevention: Evidence from Health and Demographic Surveillance in Southern Mozambique
Nhacolo, A., Madewell, Z. J., Muir, J. A., Sacoor, C., Xerinda, E. G., Matsena, T., Bassat, Q., Whitney, C. G., Mandomando, I., Cunningham, S. A.
10.1101/2023.03.31.23288026 — Posted: 2023-04-03
Pharmaceutical and Non-Pharmaceutical Interventions for Controlling the COVID-19 Pandemic
Molla, J., Farhang-Sardroodi, S., Moyles, I. R., Heffernan, J. M.
10.1101/2023.03.31.23288023 — Posted: 2023-04-03
A Graph Embedding Approach for Deciphering the Longitudinal Associations of Global Mobility and COVID-19 Cases
Awasthi, R., Modi, M., Dudeja, H., Bajaj, T., Rastogi, S., Sethi, T.
10.1101/2023.03.30.23287969 — Posted: 2023-04-03
Trends in weight gain recorded in English primary care before and during the Coronavirus-19 pandemic: an observational cohort study using the OpenSAFELY platform
Samuel, M., Park, R. Y., Eastwood, S. V., Eto, F., Morton, C. E., Stow, D., Bacon, S., Mehrkar, A., Morley, J., Dillingham, I., Inglesby, P., Hulme, W. J., Khunti, K., Mathur, R., Valabhji, J., MacKenna, B., Finer, S., The OpenSAFELY Collaborative
10.1101/2023.04.01.23287538 — Posted: 2023-04-03
A nationwide multistate analysis estimating the rates and risks of transferring critically ill COVID-19 patients during the Delta and Omicron waves in Germany
Lottes, M., Grodd, M., Grabenhenrich, L., Wolkewitz, M.
10.1101/2023.03.31.23287964 — Posted: 2023-04-03
Clinical Phenotype Prediction From Single-cell RNA-seq Data using Attention-Based Neural Networks
Mao, Y., Lin, Y.-Y., Wong, N. K. Y., Volik, S., Sar, F., Collins, C., Ester, M.
10.1101/2023.03.31.532253 — Posted: 2023-04-02
Long-term duration of protection of ancestral-strain monovalent vaccines and effectiveness of the bivalent BA.1 boosters against COVID-19 hospitalisation during a period of BA.5, BQ.1, CH.1.1. and XBB.1.5 circulation in England
Kirsebom, F., Andrews, N., Stowe, J., Ramsay, M., Lopez Bernal, J.
10.1101/2023.03.31.23288018 — Posted: 2023-03-31
Covid-19 and post-acute sick leave: a hybrid register and questionnaire study in the adult Danish population
O'Regan, E., Svaalgard, I. B., Soerensen, A. I. V., Spiliopoulos, L., Bager, P., Nielsen, N. M., Vinsloev Hansen, J., Koch, A., Ethelberg, S., Hviid, A.
10.1101/2023.03.31.23288004 — Posted: 2023-03-31
Robust immunogenicity of a third BNT162b2 vaccination against SARS-CoV-2 Omicron variant in a naive New Zealand cohort
Lavender, B., Hooker, C., Frampton, C., Williams, M., Carson, S., Paterson, A., McGregor, R., Moreland, N. J., Gell, K., Priddy, F. H., Wiig, K., Le Gros, G., Ussher, J. E., Brewerton, M.
10.1101/2023.03.30.23287981 — Posted: 2023-03-31
Blood biomarkers-defined subgroups show heterogeneity in post-acute COVID-19 syndrome: a rationale for precision medicine.
Charvet, B., Lucas, A., Pierquin, J., Brunel, J., Fried, S., Bernis, C., Orban, Z. S., Jimenez, M., Hanson, B. A., Visvabharathy, L., Koralnik, I. J., Perron, H. J.
10.1101/2023.03.31.23288003 — Posted: 2023-03-31

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).